Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Seminars in Immunology
|
December 8, 2020
Targeting novel inhibitory receptors in cancer immunotherapy
Quan-Quan Ding, Joe-Marc Chauvin, Hassane M Zarour
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L Whiteside, Sandra Demaria, Maria E Rodriguez-Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2010
Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1
Pavol Kudela, Zhaojun Sun, Julien Fourcade, et al.
Cancer Research
|
February 28, 2015
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Zhaojun Sun, Julien Fourcade, Ornella Pagliano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2010
Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire
Julien Fourcade, Zhaojun Sun, Pavol Kudela, et al.
Cancer Research
|
June 19, 2007
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling
Tatiana Raskovalova, Anna Lokshin, Xiaojun Huang, et al.
Cancer Research
|
October 16, 2003
The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells
Maja Mandic, Christine Almunia, Stephanie Vicel, et al.
The Journal of Experimental Medicine
|
September 8, 2010
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Frontiers in Oncology
|
December 12, 2022
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Saba S Shaikh, Yan Zang, Janel Hanmer, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Seminars in Immunology
|
December 8, 2020
Targeting novel inhibitory receptors in cancer immunotherapy
Quan-Quan Ding, Joe-Marc Chauvin, Hassane M Zarour
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L Whiteside, Sandra Demaria, Maria E Rodriguez-Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 7, 2010
Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1
Pavol Kudela, Zhaojun Sun, Julien Fourcade, et al.
Cancer Research
|
February 28, 2015
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Zhaojun Sun, Julien Fourcade, Ornella Pagliano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2010
Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire
Julien Fourcade, Zhaojun Sun, Pavol Kudela, et al.
Cancer Research
|
June 19, 2007
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling
Tatiana Raskovalova, Anna Lokshin, Xiaojun Huang, et al.
Cancer Research
|
October 16, 2003
The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells
Maja Mandic, Christine Almunia, Stephanie Vicel, et al.
The Journal of Experimental Medicine
|
September 8, 2010
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2008
Next generation of immunotherapy for melanoma
John M Kirkwood, Ahmad A Tarhini, Monica C Panelli, et al.
Frontiers in Oncology
|
December 12, 2022
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Saba S Shaikh, Yan Zang, Janel Hanmer, et al.
Page
of 6